Status:

NOT_YET_RECRUITING

Evaluation of a Personalizable Pessary for Pelvic Organ Prolapse

Lead Sponsor:

University of Alberta

Collaborating Sponsors:

Alberta Innovates Health Solutions

Cosm Medical

Conditions:

Pelvic Organ Prolapse (POP)

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Pelvic organ prolapse (POP) is a common health issue. It will impact about half of Canadian women over their lifetime. With POP, organs like the bladder, uterus, and bowel may push into the vagina. Wo...

Detailed Description

Purpose: Pelvic organ prolapse (POP) impacts 50% of Canadian women in their lifetime. POP can be associated with voiding dysfunction, bowel dysfunction, and sexual dysfunction, thereby impacting quali...

Eligibility Criteria

Inclusion

  • Patients assigned female at birth
  • At least 18 years old at time of screening
  • Patients with symptomatic POP using a pessary for ≥ 3 months
  • Capable of giving informed consent
  • Fluency in English

Exclusion

  • Pregnancy
  • Short vaginal length (total vaginal length \<5 cm) or subjective vaginal narrowing
  • Vaginal erosion due to current pessary
  • Presence of vesicovaginal fistula
  • Presence of rectovaginal fistula
  • Current treatment for vaginal, rectal, or bladder tumor
  • Presence of open wound or tear near vagina or anus by exam prior to removal of current pessary
  • Presence of pelvic, vaginal, or urinary infection requiring treatment
  • Ongoing treatment of recurrent urinary tract or vaginal infections
  • Inflammatory bowel disease
  • Chronic pain syndromes of pelvic or anorectal origin
  • Previous pelvic floor surgery in last 12 months
  • Congenital malformation of bladder, rectum, or vagina
  • Significant medical condition interfering with study participation (psychologic, neurologic, active drug/alcohol abuse, ambulatory restrictions, etc.)
  • Planning pregnancy in next 6 months

Key Trial Info

Start Date :

February 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2026

Estimated Enrollment :

43 Patients enrolled

Trial Details

Trial ID

NCT06954701

Start Date

February 1 2026

End Date

October 1 2026

Last Update

January 7 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dale Sheard Centre for Solutions in Women's Health

Edmonton, Alberta, Canada, T5H3V9